Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRIPROLIDINE Cause Maternal exposure timing unspecified? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Maternal exposure timing unspecified have been filed in association with TRIPROLIDINE (Childrens PediaClear PD). This represents 10.6% of all adverse event reports for TRIPROLIDINE.

18
Reports of Maternal exposure timing unspecified with TRIPROLIDINE
10.6%
of all TRIPROLIDINE reports
18
Deaths
18
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From TRIPROLIDINE?

Of the 18 reports, 18 (100.0%) resulted in death, 18 (100.0%) required hospitalization, and 18 (100.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRIPROLIDINE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does TRIPROLIDINE Cause?

Psoriatic arthropathy (110) Type 2 diabetes mellitus (109) Pericarditis (108) Joint swelling (106) Oedema (106) Pemphigus (105) Pyrexia (105) Sinusitis (104) Urticaria (103) Injury (102)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which TRIPROLIDINE Alternatives Have Lower Maternal exposure timing unspecified Risk?

TRIPROLIDINE vs TRIPTORELIN TRIPROLIDINE vs TRISODIUM TRIPROLIDINE vs TROFINETIDE TRIPROLIDINE vs TROFOSFAMIDE TRIPROLIDINE vs TROPATEPINE

Related Pages

TRIPROLIDINE Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified TRIPROLIDINE Demographics